50531 Investors following Cipla. Share this News with them.
0
Like this story, share it with millions of investors on M3
Cipla launches drug to treat H1N1 virus
Drug maker Cipla on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.
Drug maker Cipla on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.
Cipla's Oseltamivir brand, called Antiflu, will cost Rs 475 for 10 capsules, with 75 ml syrup will be similarly priced.
Cipla's drug is also pre-qualified by the World Health Organisation.